Technology Licensing Office (TLO) @ SFU’s Post

🌟 Exciting Breakthrough in Cancer Research! 🌟 We are thrilled to share groundbreaking advancements from the research teams at Simon Fraser University, led by professors David Vocadlo and Rob Britton. This innovative technology significantly enhances therapeutic antibodies, making them far more potent in targeting various types of cancer. 🧬 Sugar-Blocking Technology: A Game Changer “𝘛𝘩𝘦 𝘪𝘮𝘱𝘳𝘰𝘷𝘦𝘥 𝘢𝘯𝘵𝘪𝘣𝘰𝘥𝘪𝘦𝘴 𝘤𝘢𝘯 𝘣𝘪𝘯𝘥 𝘶𝘱 𝘵𝘰 50-𝘧𝘰𝘭𝘥 𝘮𝘰𝘳𝘦 𝘱𝘰𝘵𝘦𝘯𝘵𝘭𝘺, 𝘮𝘢𝘬𝘪𝘯𝘨 𝘵𝘩𝘦𝘮 𝘧𝘢𝘳 𝘮𝘰𝘳𝘦 𝘦𝘧𝘧𝘦𝘤𝘵𝘪𝘷𝘦, 𝘢𝘯𝘥 𝘵𝘩𝘪𝘴 𝘤𝘢𝘯 𝘢𝘭𝘴𝘰 𝘢𝘭𝘭𝘰𝘸 𝘺𝘰𝘶 𝘵𝘰 𝘵𝘢𝘳𝘨𝘦𝘵 𝘤𝘢𝘯𝘤𝘦𝘳𝘴 𝘵𝘩𝘢𝘵 𝘺𝘰𝘶 𝘸𝘰𝘶𝘭𝘥𝘯’𝘵 𝘯𝘰𝘳𝘮𝘢𝘭𝘭𝘺 𝘣𝘦 𝘢𝘣𝘭𝘦 𝘵𝘰 𝘢𝘵𝘵𝘢𝘤𝘬 𝘶𝘴𝘪𝘯𝘨 𝘢 𝘴𝘵𝘢𝘯𝘥𝘢𝘳𝘥 𝘢𝘯𝘵𝘪-𝘤𝘢𝘯𝘤𝘦𝘳 𝘢𝘯𝘵𝘪𝘣𝘰𝘥𝘺,” explains professor Vocadlo. At Technology Licensing Office (TLO) @ SFU, we are proud to support these innovative solutions being developed and commercialized by the SFU spin-off Carbaform Biosciences, addressing pressing health challenges. This breakthrough represents a significant step forward in the fight against cancer, underscoring the power of collaboration and innovation. Read more on GlycoNet: https://lnkd.in/dwBJyhdb

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics